Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis

Autologous hematopoietic stem cell transplantation (AHSCT) to treat multiple sclerosis (MS) has mostly been used in devastating cases as the last option to stop further neurological deterioration. However, evidence from several retrospective clinical trials indicates that young, less disabled patien...

Full description

Saved in:
Bibliographic Details
Published in:Ther Adv Neurol Disord
Main Authors: Lycke, Jan, Lenhoff, Stig
Format: Artigo
Language:Inglês
Published: SAGE Publications 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7315665/
https://ncbi.nlm.nih.gov/pubmed/32636931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420929467
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items